TwitterRSSFacebookDirectors Blog
  Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

Skip secondary menu

Funding News - Applications for Parkinson’s Disease Research Requested

Archive folder iconHistorical Data

  • The information on this page is for historical and research purposes only.
  • For the most current NINDS funding announcements, please see the NINDS list of Active Funding Initiatives or Follow Us on Twitter for the latest funding news.

The National Institute of Neurological Disorders and Stroke (NINDS), the National Institute on Deafness and Other Communication Disorders (NIDCD), the National Institute of Environmental Health Sciences (NIEHS), the National Institute of Mental Health (NIMH), the Michael J. Fox Foundation for Parkinson’s Disease Research, the Parkinson’s Disease Foundation/National Parkinson’s Foundation, and the Parkinson’s Alliance request applications for fast-track (R21) grants for research on Parkinson’s disease.

Parkinson’s disease is a neurodegenerative movement disorder caused by selective degeneration of the dopaminergic neurons of the substantia nigra-a brain area critical for purposeful control of movement. The objective of this request for applications (RFA) is to stimulate novel, innovative, or high-impact research on the cure, cause, prevention, and/or improved treatment of Parkinson’s disease and its complications.

Areas of potential research interest include epidemiology, genetics, biochemistry, cell biology, physiology, and clinical studies. An important component of disease cure or prevention is the translation of basic discoveries to clinical applications, therefore studies utilizing translational or “bench-to-beside” approaches are encouraged. Collaborative efforts between basic neurobiologists and clinicians also are welcomed.


For more information, potential applicants should contact Dr. Diane Murphy, Program Director, Neurodegeneration Cluster, NINDS, Neuroscience Center, 6001 Executive Boulevard, Room 2223, Bethesda, MD 20892; telephone: (301) 496-5680; fax: (301) 480-1080; e-mail:

For a more detailed description of this RFA, please visit the NIH web site at: